공지 : 도쿄증권거래소 JASDAQ 스탠다드 시장 신규 상장 관련 안내

Global Information
회사소개 | 문의 | 비교리스트

세계의 암 단클론항체 시장 보고서(2021년판) : COVID-19 확대와 변화(-2030년)

Cancer Monoclonal Antibodies Global Market Report 2021: COVID-19 Growth And Change To 2030

리서치사 The Business Research Company
발행일 On Demand Report 상품 코드 1028946
페이지 정보 영문 175 Pages
가격
US $ 5,000 ₩ 5,987,000 PDF (Single User License)
US $ 7,500 ₩ 8,981,000 PDF (Site License)
US $ 10,000 ₩ 11,975,000 PDF (Enterprise License)


세계의 암 단클론항체 시장 보고서(2021년판) : COVID-19 확대와 변화(-2030년) Cancer Monoclonal Antibodies Global Market Report 2021: COVID-19 Growth And Change To 2030
발행일 : On Demand Report 페이지 정보 : 영문 175 Pages

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 암 단클론항체(Cancer Monoclonal Antibodies) 시장에 대해 조사했으며, 시장 특성, 규모와 성장, 세분화, 지역/국가별 동향, 경쟁 구도, 시장 점유율, 시장 동향, 지역별 시장 실적과 예측, 시장 진출기업 프로파일 등의 정보를 정리하여 전해드립니다.

목차

제1장 개요

제2장 암 단클론항체 시장의 특징

제3장 암 단클론항체 시장 동향과 전략

제4장 암 단클론항체에 대한 COVID-19의 영향

제5장 암 단클론항체 시장 규모와 성장

  • 세계의 암 단클론항체 시장 실적, 2015-2020년, 10억 달러
    • 성장 촉진요인
    • 성장 억제요인
  • 세계의 암 단클론항체 시장 예측, 2020-2025년, 2030년, 10억 달러
    • 성장 촉진요인
    • 성장 억제요인

제6장 암 단클론항체 시장 세분화

  • 세계의 암 단클론항체 시장, 단클론항체 요법별 세분화, 실적과 예측, 2015-2020년, 2020-2025년, 2030년, 10억 달러
  • Bevacizumab (Avastin)
  • Rituximab (Rituxan)
  • Trastuzumab (Herceptin)
  • Cetuximab (Erbitux)
  • Panitumumab (Vectibix)
  • 기타
  • 세계의 암 단클론항체 시장, 용도별 세분화, 실적과 예측, 2015-2020년, 2020-2025년, 2030년, 10억 달러
  • 유방암
  • 혈액암
  • 간암
  • 뇌종양
  • 대장암
  • 기타
  • 세계의 암 단클론항체 시장, 최종사용자별 세분화, 역사와 예측, 2015-2020년, 2020-2025년, 2030년, 10억 달러
  • 병원/진료소
  • 연구
  • 약국
  • 기타

제7장 암 단클론항체 시장 지역별 및 국가별 분석

  • 세계의 암 단클론항체 시장, 지역별, 실적과 예측, 2015-2020년, 2020-2025년, 2030년, 10억 달러
  • 세계의 암 단클론항체 시장, 국가별, 실적과 예측, 2015-2020년, 2020-2025년, 2030년, 10억 달러

제8장 아시아태평양의 암 단클론항체 시장

  • 아시아태평양의 암 단클론항체 시장 개요
  • 지역 정보, COVID-19의 영향, 시장 정보, 배경 정보, 정부 이니셔티브, 규제, 규제기관, 주요 협회, 면세, 법인세 구조, 투자, 주요 기업
  • 아시아태평양의 암 단클론항체 시장, 단클론항체 요법별 세분화, 역사와 예측, 2015-2020년, 2020-2025년, 2030년, 10억 달러

제9장 중국의 암 단클론항체 시장

  • 중국의 암 단클론항체 시장 개요
  • 중국의 암 단클론항체 시장, 단클론항체 요법별 세분화, 실적과 예측, 2015-2020년, 2020-2025년, 2030년, 10억 달러

제10장 인도의 암 단클론항체 시장

  • 인도의 암 단클론항체 시장, 단클론항체 요법별 세분화, 실적과 예측, 2015-2020년, 2020-2025년, 2030년, 10억 달러

제11장 일본의 암 단클론항체 시장

  • 일본의 암 단클론항체 시장, 단클론항체 요법별 세분화, 역사와 예측, 2015-2020년, 2020-2025년, 2030년, 10억 달러

제12장 호주의 암 단클론항체 시장

  • 호주의 암 단클론항체 시장, 단클론항체 요법별 세분화, 실적과 예측, 2015-2020년, 2020-2025년, 2030년, 10억 달러

제13장 인도네시아의 암 단클론항체 시장

  • 인도네시아의 암 단클론항체 시장, 단클론항체 요법별 세분화, 실적과 예측, 2015-2020년, 2020-2025년, 2030년, 10억 달러

제14장 한국의 암 단클론항체 시장

  • 한국의 암 단클론항체 시장, 단클론항체 요법별 세분화, 역사와 예측, 2015-2020년, 2020-2025년, 2030년, 10억 달러

제15장 서유럽의 암 단클론항체 시장

  • 서유럽의 암 단클론항체 시장 개요
  • 서유럽의 암 단클론항체 시장, 단클론항체 요법별 세분화, 실적과 예측, 2015-2020년, 2020-2025년, 2030년, 10억 달러

제16장 영국의 암 단클론항체 시장

  • 영국의 암 단클론항체 시장, 단클론항체 요법별 세분화, 실적과 예측, 2015-2020년, 2020-2025년, 2030년, 10억 달러

제17장 독일의 암 단클론항체 시장

  • 독일의 암 단클론항체 시장, 단클론항체 요법별 세분화, 실적과 예측, 2015-2020년, 2020-2025년, 2030년, 10억 달러

제18장 프랑스의 암 단클론항체 시장

  • 프랑스의 암 단클론항체 시장, 단클론항체 요법별 세분화, 실적과 예측, 2015-2020년, 2020-2025년, 2030년, 10억 달러

제19장 동유럽의 암 단클론항체 시장

  • 동유럽의 암 단클론항체 시장 개요
  • 동유럽의 암 단클론항체 시장, 단클론항체 요법별 세분화, 실적과 예측, 2015-2020년, 2020-2025년, 2030년, 10억 달러

제20장 러시아의 암 단클론항체 시장

  • 러시아의 암 단클론항체 시장, 단클론항체 요법별 세분화, 실적과 예측, 2015-2020년, 2020-2025년, 2030년, 10억 달러

제21장 북미의 암 단클론항체 시장

  • 북미의 암 단클론항체 시장 개요
  • 북미의 암 단클론항체 시장, 단클론항체 요법별 세분화, 실적과 예측, 2015-2020년, 2020-2025년, 2030년, 10억 달러

제22장 미국의 암 단클론항체 시장

  • 미국의 암 단클론항체 시장 개요
  • 미국의 암 단클론항체 시장, 단클론항체 요법별 세분화, 실적과 예측, 2015-2020년, 2020-2025년, 2030년, 10억 달러

제23장 남미의 암 단클론항체 시장

  • 남미의 암 단클론항체 시장 개요
  • 남미의 암 단클론항체 시장, 단클론항체 요법별 세분화, 역사와 예측, 2015-2020년, 2020-2025년, 2030년, 10억 달러

제24장 브라질의 암 단클론항체 시장

  • 브라질의 암 단클론항체 시장, 단클론항체 요법별 세분화, 실적과 예측, 2015-2020년, 2020-2025년, 2030년, 10억 달러

제25장 중동의 암 단클론항체 시장

  • 중동의 암 단클론항체 시장 개요
  • 중동의 암 단클론항체 시장, 단클론항체 요법별 세분화, 실적과 예측, 2015-2020년, 2020-2025년, 2030년, 10억 달러

제26장 아프리카의 암 단클론항체 시장

  • 아프리카의 암 단클론항체 시장 개요
  • 아프리카의 암 단클론항체 시장, 단클론항체 요법별 세분화, 실적과 예측, 2015-2020년, 2020-2025년, 2030년, 10억 달러

제27장 암 단클론항체 시장 경쟁 구도와 기업 개요

  • 암 단클론항체 시장 경쟁 구도
  • 암 단클론항체 시장 기업 개요
    • Amgen
    • Bristol Myers Squibb Company
    • Eli Lilly and Company
    • F. Hoffmann-La Roche Ltd
    • Genmab AS

제28장 암 단클론항체 파이프라인 분석

제29장 암 단클론항체 시장의 주요 인수합병(M&A)

제30장 암 단클론항체 시장 전망과 잠재성 분석

제31장 부록

LSH 21.10.08

Cancer Monoclonal Antibodies Global Market Report 2021: COVID-19 Growth And Change to 2030 from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global cancer monoclonal antibodies (mabs) market.

This report focuses on cancer monoclonal antibodies (mabs) market which is experiencing strong growth. The report gives a guide to the cancer monoclonal antibodies (mabs) market which will be shaping and changing our lives over the next ten years and beyond, including the markets response to the challenge of the global pandemic.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Where is the largest and fastest growing market for the cancer monoclonal antibodies (mabs)? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Cancer Monoclonal Antibodies (mAbs) market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider cancer monoclonal antibodies (mabs) market, and compares it with other markets.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the COVID-19 virus and forecasting its growth.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The cancer monoclonal antibodies (mabs) market section of the report gives context. It compares the cancer monoclonal antibodies (mabs) market with other segments of the cancer monoclonal antibodies (mabs) market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, cancer monoclonal antibodies (mabs) indicators comparison.

Scope

Markets Covered:

1) By Monoclonal Antibody Therapies: Bevacizumab (Avastin); Rituximab (Rituxan); Trastuzumab (Herceptin); Cetuximab (Erbitux); Panitumumab (Vectibix); Others

2) By Application: Breast Cancer; Blood Cancer; Liver Cancer; Brain Cancer; Colorectal Cancer; Others

3) By End User: Hospitals And Clinics; Research Laboratories; Pharmacies; Others

Companies Mentioned: Amgen; Bristol Myers Squibb Company; Eli Lilly and Company; F. Hoffmann-La Roche Ltd; Genmab AS

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Executive Summary

2. Cancer Monoclonal Antibodies Market Characteristics

3. Cancer Monoclonal Antibodies Market Trends And Strategies

4. Impact Of COVID-19 On Cancer Monoclonal Antibodies

5. Cancer Monoclonal Antibodies Market Size And Growth

  • 5.1. Global Cancer Monoclonal Antibodies Historic Market, 2015-2020, $ Billion
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints On The Market
  • 5.2. Global Cancer Monoclonal Antibodies Forecast Market, 2020-2025F, 2030F, $ Billion
    • 5.2.1. Drivers Of The Market
    • 5.2.2. Restraints On the Market

6. Cancer Monoclonal Antibodies Market Segmentation

  • 6.1. Global Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Bevacizumab (Avastin)
  • Rituximab (Rituxan)
  • Trastuzumab (Herceptin)
  • Cetuximab (Erbitux)
  • Panitumumab (Vectibix)
  • Others
  • 6.2. Global Cancer Monoclonal Antibodies Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Breast Cancer
  • Blood Cancer
  • Liver Cancer
  • Brain Cancer
  • Colorectal Cancer
  • Others
  • 6.3. Global Cancer Monoclonal Antibodies Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Hospitals and Clinics
  • Research Laboratories
  • Pharmacies
  • Others

7. Cancer Monoclonal Antibodies Market Regional And Country Analysis

  • 7.1. Global Cancer Monoclonal Antibodies Market, Split By Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 7.2. Global Cancer Monoclonal Antibodies Market, Split By Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

8. Asia-Pacific Cancer Monoclonal Antibodies Market

  • 8.1. Asia-Pacific Cancer Monoclonal Antibodies Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

9. China Cancer Monoclonal Antibodies Market

  • 9.1. China Cancer Monoclonal Antibodies Market Overview
  • 9.2. China Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion

10. India Cancer Monoclonal Antibodies Market

  • 10.1. India Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

11. Japan Cancer Monoclonal Antibodies Market

  • 11.1. Japan Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

12. Australia Cancer Monoclonal Antibodies Market

  • 12.1. Australia Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

13. Indonesia Cancer Monoclonal Antibodies Market

  • 13.1. Indonesia Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

14. South Korea Cancer Monoclonal Antibodies Market

  • 14.1. South Korea Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

15. Western Europe Cancer Monoclonal Antibodies Market

  • 15.1. Western Europe Cancer Monoclonal Antibodies Market Overview
  • 15.2. Western Europe Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

16. UK Cancer Monoclonal Antibodies Market

  • 16.1. UK Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

17. Germany Cancer Monoclonal Antibodies Market

  • 17.1. Germany Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

18. France Cancer Monoclonal Antibodies Market

  • 18.3. France Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

19. Eastern Europe Cancer Monoclonal Antibodies Market

  • 19.1. Eastern Europe Cancer Monoclonal Antibodies Market Overview
  • 19.2. Eastern Europe Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

20. Russia Cancer Monoclonal Antibodies Market

  • 20.1. Russia Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

21. North America Cancer Monoclonal Antibodies Market

  • 21.1. North America Cancer Monoclonal Antibodies Market Overview
  • 21.2. North America Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

22. USA Cancer Monoclonal Antibodies Market

  • 22.1. USA Cancer Monoclonal Antibodies Market Overview
  • 22.2. USA Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

23. South America Cancer Monoclonal Antibodies Market

  • 23.1. South America Cancer Monoclonal Antibodies Market Overview
  • 23.2. South America Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

24. Brazil Cancer Monoclonal Antibodies Market

  • 24.1. Brazil Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

25. Middle East Cancer Monoclonal Antibodies Market

  • 25.1. Middle East Cancer Monoclonal Antibodies Market Overview
  • 25.2. Middle East Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

26. Africa Cancer Monoclonal Antibodies Market

  • 26.1. Africa Cancer Monoclonal Antibodies Market Overview
  • 26.2. Africa Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

27. Cancer Monoclonal Antibodies Market Competitive Landscape And Company Profiles

  • 27.1. Cancer Monoclonal Antibodies Market Competitive Landscape
  • 27.2. Cancer Monoclonal Antibodies Market Company Profiles
    • 27.2.1. Amgen
      • 27.2.1.1. Overview
      • 27.2.1.2. Products and Services
      • 27.2.1.3. Strategy
      • 27.2.1.4. Financial Performance
    • 27.2.2. Bristol Myers Squibb Company
      • 27.2.2.1. Overview
      • 27.2.2.2. Products and Services
      • 27.2.2.3. Strategy
      • 27.2.2.4. Financial Performance
    • 27.2.3. Eli Lilly and Company
      • 27.2.3.1. Overview
      • 27.2.3.2. Products and Services
      • 27.2.3.3. Strategy
      • 27.2.3.4. Financial Performance
    • 27.2.4. F. Hoffmann-La Roche Ltd
      • 27.2.4.1. Overview
      • 27.2.4.2. Products and Services
      • 27.2.4.3. Strategy
      • 27.2.4.4. Financial Performance
    • 27.2.5. Genmab AS
      • 27.2.5.1. Overview
      • 27.2.5.2. Products and Services
      • 27.2.5.3. Strategy
      • 27.2.5.4. Financial Performance

28. Cancer Monoclonal Antibodies Pipeline Analysis

29. Key Mergers And Acquisitions In The Cancer Monoclonal Antibodies Market

30. Cancer Monoclonal Antibodies Market Future Outlook and Potential Analysis

31. Appendix

  • 31.1. Abbreviations
  • 31.2. Currencies
  • 31.3. Research Inquiries
  • 31.4. The Business Research Company
  • 31.5. Copyright And Disclaimer
Back to Top
전화 문의
F A Q